National Center for Research Resources; Notice of Closed Meetings, 11798-11799 [2011-4825]
Download as PDF
<![CDATA[
11798
Federal Register / Vol. 76, No. 42 / Thursday, March 3, 2011 / Notices
drug products covered by this notice
that are marketed under an NDC number
listed with the Agency in full
compliance with section 510 of the
FD&C Act before March 2, 2011. As
previously stated, drug products
covered by this notice that are currently
marketed but not listed with the Agency
on the date of this notice must, as of the
effective date of this notice, have
approved applications prior to their
shipment in interstate commerce.
Moreover, any person or firm that has
submitted or submits an application but
has yet to receive approval for such
products is still responsible for full
compliance with this notice.
V. Discontinued Products
Some firms may have previously
discontinued the manufacturing or
distribution of products covered by this
notice without removing them from the
listing of their products under section
510(j) of the FD&C Act. Other firms may
discontinue manufacturing or marketing
listed products in response to this
notice. Firms that wish to notify the
Agency of product discontinuation
should send a letter, signed by the firm’s
chief executive officer, fully identifying
the discontinued product(s), including
NDC number(s), and stating that the
product(s) has (have) been
discontinued. The letter should be sent
to Sakineh Walther (see ADDRESSES).
Firms should also update the listing of
their products under section 510(j) of
the FD&C Act to reflect discontinuation
of products covered by this notice. FDA
plans to rely on its existing records,
including its drug listing records, or
other available information when it
targets violations for enforcement
action.
This notice is issued under the
Federal Food, Drug, and Cosmetic Act
(sections 502 and 505 (21 U.S.C. 352
and 355)) and under authority delegated
to the Assistant Commissioner for
Policy under section 1410.21 of the FDA
Staff Manual Guide.
Dated: February 22, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
srobinson on DSKHWCL6B1PROD with NOTICES
[FR Doc. 2011–4703 Filed 3–2–11; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
National Institutes of Health
Advisory Committee on Organ
Transplantation; Notice of Meeting
Health Resources and Services
Administration, HHS.
AGENCY:
ACTION:
Notice; correction.
The Health Resources and
Services Administration published a
notice in the Federal Register of
February 9, 2011 (76 FR 7223–7224)
announcing an Advisory Committee on
Organ Transplantation meeting on
March 8, 2011. The type of meeting,
time and place have been changed.
SUMMARY:
Correction
In the Federal Register of February 9,
2011, in FR Doc. 2011–2839, on page
7223, 2nd column, under the heading
Department of Health and Human
Services, Health Resources and Services
Administration, Advisory Committee on
Organ Transplantation; Notice of
Meeting, change the Times and Place to
read:
The meeting will be an Audio
Conference Call on March 8, 2011, from
12 noon to 4 p.m. EST. To access the
conference call, call the USA Toll Free
Number 888–469–1090 and enter the
Passcode 2741198. The conference call
leader is Patricia A. Stroup. Participants
should call no later than 11:45 a.m. EST
in order for logistics to be set up.
Participants are asked to register for the
conference call by contacting Brittany
Carey, HRM/Professional and Scientific
Associates (PSA), the logistical support
contractor for the meeting, at (703) 889–
9033 or b_carey@team-psa.com. The
registration deadline is March 7, 2011.
The Department will try to
accommodate those wishing to
participate in the call.
The next face-to-face ACOT meeting
is planned for August 2011. Details
regarding an August meeting will be
published in a subsequent Federal
Register notice.
Reva Harris,
Acting Director, Division of Policy and
Information Coordination.
BILLING CODE 4160–01–P
[FR Doc. 2011–4755 Filed 3–2–11; 8:45 am]
BILLING CODE 4165–15–P
VerDate Mar<15>2010
16:47 Mar 02, 2011
Jkt 223001
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Member
Conflict.
Date: March 15, 2011.
Time: 9 a.m. to 10 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Suite 2C212, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Ramesh Vemuri, PhD,
Chief, Scientific Review Branch, National
Institute on Aging, National Institutes of
Health, 7201 Wisconsin Avenue, Suite 2C–
212, Bethesda, MD 20892, 301–402–7700,
rv23r@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: February 25, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–4826 Filed 3–2–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Research
Resources; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
E:\FR\FM\03MRN1.SGM
03MRN1
Federal Register / Vol. 76, No. 42 / Thursday, March 3, 2011 / Notices
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
srobinson on DSKHWCL6B1PROD with NOTICES
Name of Committee: National Center for
Research Resources Special Emphasis Panel;
Animal Models.
Date: March 15, 2011.
Time: 8 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Democracy I, 6701 Democracy Blvd., 1078,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Steven Birken, PhD,
Scientific Review Officer, Office of Review,
National Center for Research Resources,
National Institutes of Health, 6701
Democracy Blvd., 10th Fl., Bethesda, MD
20892, (301) 435–1078,
birkens@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Center for
Research Resources Special Emphasis Panel;
CTSA Coordinating Center.
Date: March 28, 2011.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Democracy I, 6701 Democracy Blvd., 1064,
Bethesda, MD 20892–4874 (Telephone
Conference Call).
Contact Person: Guo Zhang, PhD, Scientific
Review Officer, Office of Review, National
Center for Research Resources, National
Institutes of Health, 6701 Democracy Blvd.,
Dem. 1, Room 1064, MSC 4874, Bethesda,
MD 20892–4874, 301–435–0812,
zhanggu@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research; 93.371, Biomedical
Technology; 93.389, Research Infrastructure,
93.306, 93.333; 93.702, ARRA Related
Construction Awards, National Institutes of
Health, HHS)
Dated: February 25, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–4825 Filed 3–2–11; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Novel Drug Targets.
Date: March 23, 2011.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, 3147, Bethesda, MD 20817
(Telephone Conference Call).
Contact Person: Jane K. Battles, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institutes of Health/NIAID, 6700B
Rockledge Drive, MSC 7616, Bethesda, MD
20892–7616, 301–451–2744,
battlesja@mail.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Host-Pathogen Interactions.
Date: March 24, 2011.
Time: 12:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, 3147, Bethesda, MD 20817
(Telephone Conference Call).
Contact Person: Jane K. Battles, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institutes of Health/NIAID, 6700B
Rockledge Drive, MSC 7616, Bethesda, MD
20892–7616, 301–451–2744,
battlesja@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Consortia for AIDS Vaccine
Research in Nonhuman Primates.
Date: March 29–30, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Georgetown, 2101
Wisconsin Avenue, NW., Washington, DC
20007.
Contact Person: Lynn Rust, PhD, Scientific
Review Officer, Scientific Review Program,
Division of Extramural Activities, National
Institutes of Health/NIAID, 6700B Rockledge
Drive, MSC 7616, Bethesda, MD 20892–7616,
301–496–2550.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: February 25, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
[FR Doc. 2011–4824 Filed 3–2–11; 8:45 am]
BILLING CODE 4140–01–P
VerDate Mar<15>2010
16:47 Mar 02, 2011
Jkt 223001
11799
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
Dated: February 25, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–4823 Filed 3–2–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
E:\FR\FM\03MRN1.SGM
03MRN1
]]>Agencies
[Federal Register Volume 76, Number 42 (Thursday, March 3, 2011)]
[Notices]
[Pages 11798-11799]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-4825]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Research Resources; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections
[[Page 11799]]
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant
applications and the discussions could disclose confidential trade
secrets or commercial property such as patentable material, and
personal information concerning individuals associated with the grant
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Center for Research Resources
Special Emphasis Panel; Animal Models.
Date: March 15, 2011.
Time: 8 a.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Democracy I, 6701
Democracy Blvd., 1078, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Steven Birken, PhD, Scientific Review Officer,
Office of Review, National Center for Research Resources, National
Institutes of Health, 6701 Democracy Blvd., 10th Fl., Bethesda, MD
20892, (301) 435-1078, birkens@mail.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Center for Research Resources
Special Emphasis Panel; CTSA Coordinating Center.
Date: March 28, 2011.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Democracy I, 6701
Democracy Blvd., 1064, Bethesda, MD 20892-4874 (Telephone Conference
Call).
Contact Person: Guo Zhang, PhD, Scientific Review Officer,
Office of Review, National Center for Research Resources, National
Institutes of Health, 6701 Democracy Blvd., Dem. 1, Room 1064, MSC
4874, Bethesda, MD 20892-4874, 301-435-0812, zhanggu@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research; 93.371, Biomedical
Technology; 93.389, Research Infrastructure, 93.306, 93.333; 93.702,
ARRA Related Construction Awards, National Institutes of Health,
HHS)
Dated: February 25, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-4825 Filed 3-2-11; 8:45 am]
BILLING CODE 4140-01-P
